In a separate study, significantly elevated levels of DNAm were identified in the promoter region of PTPN22 in young patients with HT, relative to controls; this verified the role of PTPN22 as an epigenetically determined susceptibility gene for thyroid autoimmunity (7). This evidence concerns the gene PTPN22 and autoimmune thyroid disease.